Guardian Pharmacy Services, Stock Analysis

Guardian Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.38. Guardian Pharmacy had not issued any dividends in recent years. To learn more about Guardian Pharmacy Services, call Fred Burke at 404 810 0089 or check out https://guardianpharmacy.com.

Guardian Pharmacy Investment Alerts

Guardian Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.25 B.

Guardian Profitablity

The company has Profit Margin (PM) of (0.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.33.

Management Efficiency

At this time, Guardian Pharmacy's Non Currrent Assets Other are very stable compared to the past year. As of the 27th of March 2025, Intangible Assets is likely to grow to about 12.5 M, while Total Assets are likely to drop about 269.8 M. Guardian Pharmacy's management efficiency ratios could be used to measure how well Guardian Pharmacy manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 27th of March, Guardian Pharmacy retains the market risk adjusted performance of (0.04), and Risk Adjusted Performance of (0.01). Guardian Pharmacy technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Guardian Pharmacy Price Movement Analysis

Guardian Pharmacy Predictive Daily Indicators

Guardian Pharmacy Corporate Filings

Guardian Pharmacy Forecast Models

Guardian Pharmacy's time-series forecasting models are one of many Guardian Pharmacy's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Guardian Pharmacy's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardian Pharmacy prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Guardian shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Guardian Pharmacy. By using and applying Guardian Stock analysis, traders can create a robust methodology for identifying Guardian entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.